Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Notice of Annual General Meeting 2024
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: The subscription period in Curasight’s rights issue begins today
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight publishes information memorandum in connection with forthcoming rights issue
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Annual Report for the fiscal year 2023
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Year-end report October – December 2023
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Year-end report October – December 2023
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight resolves on a rights issue of up to DKK 51.2 million to accelerate its therapeutic strategy
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S Achieves First Milestone under collaboration with Curium Inc.
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S submits clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients